Benzinga
Benzinga
Benzinga
mercoledì, settembre 30

Cardinal Health Inc

CAHNYSE
Trade with Public
Trade with Public
$225.25
1.340.6%
Ult. Agg.: Sep 30, 11:26 AM
Dividendo: La data di stacco del dividendo è domani
PanoramicaNotiziePrevisioni utiliEventiObiettivi di prezzoDati finanziariSentimentAzionariatoDividendiConfrontaOpzioniRapporto azionario

Cardinal Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for Cardinal Health (CAH).

Price Target Range — 12 Quarters

Analyst Consensus — 17 Analysts

15Buy
2Hold
Consensus RatingBuy# Analysts17Avg. Consensus PT$224Upside to Avg. PT-0.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →
DateFirmAnalystActionRating ChangePrice Target
Aug 19, 2026RBC CapitalRyan HalstedInitiateOutperform$276
Aug 13, 2026TD CowenCharles RhyeePT RaiseBuy$275→$280
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
RBC Capital Initiates Coverage On Cardinal Health with Outperform Rating, Announces Price Target of $276

RBC Capital analyst Ryan Halsted initiates coverage on Cardinal Health (NYSE:CAH) with a Outperform rating and announces Price Target of $276.
Benzinga Newsdesk

PRO
TD Cowen Maintains Buy on Cardinal Health, Raises Price Target to $280

TD Cowen analyst Charles Rhyee maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $275 to $280.
Benzinga Newsdesk

PRO
JP Morgan Maintains Neutral on Cardinal Health, Raises Price Target to $260

JP Morgan analyst Lisa Gill maintains Cardinal Health (NYSE:CAH) with a Neutral and raises the price target from $215 to $260.
Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Cardinal Health, Raises Price Target to $275

Barclays analyst Glen Santangelo maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $258 to $275.
Benzinga Newsdesk

PRO
Evercore ISI Group Maintains Outperform on Cardinal Health, Raises Price Target to $270

Evercore ISI Group analyst Elizabeth Anderson maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $265 to $270.
Benzinga Newsdesk

PRO
Morgan Stanley Maintains Overweight on Cardinal Health, Raises Price Target to $265

Morgan Stanley analyst Erin Wright maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $255 to $265.
Benzinga Newsdesk

Dati e API: API Benzinga · API notizie azionarie · API valutazioni analisti · API logo aziende

Dati di mercato forniti da API Benzinga

Benzinga

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

© 2026 Benzinga | All Rights Reserved